Chatham Capital Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $250K | Sell |
689
-210
| -23% | -$71.9K | 0.03% | 191 |
|
|
2026
Q1 | $316K | Hold |
899
| – | – | 0.05% | 183 |
|
|
2025
Q4 | $294K | Hold |
899
| – | – | 0.04% | 186 |
|
|
2025
Q3 | $254K | Sell |
899
-180
| -17% | -$52.2K | 0.04% | 190 |
|
|
2025
Q2 | $301K | Sell |
1,079
-450
| -29% | -$127K | 0.05% | 183 |
|
|
2025
Q1 | $476K | Hold |
1,529
| – | – | 0.08% | 151 |
|
|
2024
Q4 | $399K | Hold |
1,529
| – | – | 0.07% | 162 |
|
|
2024
Q3 | $493K | Buy |
1,529
+10
| +0.7% | +$3.27K | 0.08% | 150 |
|
|
2024
Q2 | $475K | Hold |
1,519
| – | – | 0.08% | 149 |
|
|
2024
Q1 | $432K | Hold |
1,519
| – | – | 0.08% | 155 |
|
|
2023
Q4 | $438K | Hold |
1,519
| – | – | 0.09% | 150 |
|
|
2023
Q3 | $408K | Buy |
1,519
+9
| +0.6% | +$2.25K | 0.09% | 148 |
|
|
2023
Q2 | $335K | Sell |
1,510
-16
| -1% | -$3.71K | 0.07% | 160 |
|
|
2023
Q1 | $369K | Hold |
1,526
| – | – | 0.08% | 154 |
|
|
2022
Q4 | $401K | Hold |
1,526
| – | – | 0.09% | 153 |
|
|
2022
Q3 | $344K | Hold |
1,526
| – | – | 0.08% | 149 |
|
|
2022
Q2 | $371K | Buy |
1,526
+12
| +0.8% | +$2.94K | 0.08% | 148 |
|
|
2022
Q1 | $366K | Hold |
1,514
| – | – | 0.07% | 150 |
|
|
2021
Q4 | $341K | Hold |
1,514
| – | – | 0.06% | 161 |
|
|
2021
Q3 | $322K | Sell |
1,514
-92
| -6% | -$21.2K | 0.06% | 161 |
|
|
2021
Q2 | $391K | Hold |
1,606
| – | – | 0.08% | 151 |
|
|
2021
Q1 | $400K | Hold |
1,606
| – | – | 0.08% | 143 |
|
|
2020
Q4 | $369K | Buy |
1,606
+75
| +5% | +$17.3K | 0.08% | 138 |
|
|
2020
Q3 | $389K | Hold |
1,531
| – | – | 0.1% | 126 |
|
|
2020
Q2 | $361K | Sell |
1,531
-89
| -5% | -$20.3K | 0.09% | 130 |
|
|
2020
Q1 | $328K | Hold |
1,620
| – | – | 0.1% | 134 |
|
|
2019
Q4 | $391K | Hold |
1,620
| – | – | 0.1% | 134 |
|
|
2019
Q3 | $313K | Hold |
1,620
| – | – | 0.08% | 138 |
|
|
2019
Q2 | $299K | Hold |
1,620
| – | – | 0.08% | 141 |
|
|
2019
Q1 | $308K | Sell |
1,620
-200
| -11% | -$38.2K | 0.08% | 138 |
|
|
2018
Q4 | $354K | Sell |
1,820
-11
| -0.6% | -$2.15K | 0.1% | 129 |
|
|
2018
Q3 | $380K | Hold |
1,831
| – | – | 0.1% | 122 |
|
|
2018
Q2 | $338K | Buy |
1,831
+92
| +5% | +$16.3K | 0.09% | 120 |
|
|
2018
Q1 | $296K | Hold |
1,739
| – | – | 0.08% | 120 |
|
|
2017
Q4 | $302K | Sell |
1,739
-550
| -24% | -$97.3K | 0.08% | 122 |
|
|
2017
Q3 | $427K | Hold |
2,289
| – | – | 0.12% | 111 |
|
|
2017
Q2 | $394K | Sell |
2,289
-41
| -2% | -$6.67K | 0.11% | 118 |
|
|
2017
Q1 | $382K | Buy |
2,330
+41
| +2% | +$6.81K | 0.11% | 117 |
|
|
2016
Q4 | $335K | Sell |
2,289
-80
| -3% | -$12K | 0.1% | 117 |
|
|
2016
Q3 | $395K | Hold |
2,369
| – | – | 0.12% | 112 |
|
|
2016
Q2 | $360K | Hold |
2,369
| – | – | 0.11% | 112 |
|
|
2016
Q1 | $355K | Hold |
2,369
| – | – | 0.11% | 110 |
|
|
2015
Q4 | $385K | Hold |
2,369
| – | – | 0.12% | 109 |
|
|
2015
Q3 | $328K | Sell |
2,369
-75
| -3% | -$11.8K | 0.11% | 114 |
|
|
2015
Q2 | $375K | Hold |
2,444
| – | – | 0.11% | 123 |
|
|
2015
Q1 | $391K | Buy |
2,444
+80
| +3% | +$12.6K | 0.11% | 123 |
|
|
2014
Q4 | $377K | Hold |
2,364
| – | – | 0.11% | 128 |
|
|
2014
Q3 | $332K | Buy |
+2,364
| New | +$309K | 0.1% | 128 |
|
Other funds holding AMGN
FFM
SP
Chatham Capital Group's AMGN Position: Q2 2026 in Review
Chatham Capital Group reduced its Amgen (AMGN) stake by 23% in Q2 2026, selling an estimated $71.9K and leaving 689 shares worth $250K. The position accounts for 0.03% of the portfolio, ranked #191.
Chatham Capital Group first reported a position in AMGN in Q3 2014 and has held it in 48 quarters since. The position peaked at $493K in Q3 2024. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Chatham Capital Group held 689 shares of Amgen worth $250K as of Q2 2026.
- Chatham Capital Group sold 210 Amgen shares in Q2 2026, an estimated $71.9K.
- Amgen made up 0.03% of Chatham Capital Group's portfolio in Q2 2026, its #191 holding.
- Chatham Capital Group first reported a position in Amgen in Q3 2014 and has held it in 48 quarters since.
- Chatham Capital Group's Amgen position peaked at $493K in Q3 2024.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Chatham Capital Group's 13F filing for Q2 2026, filed 13 Jul 2026.